Bremelanotide becomes the second FDA-approved drug for hypoactive sexual desire disorder in premenopausal women. It is self-injected at least 45 minutes before sexual activity.
News Alerts …read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
